James Murrough: Clinical Trials

3 trials sponsored by James Murrough, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow James Murrough: new trials by email

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Study of Harmine in Healthy Subjects
Harmine Hydrochloride Capsules - Diabetes Mellitus
Phase 1CompletedJames Murrough272022-09-132025-01-16
A Dose Escalation Study of Intranasal Neuropeptide Y in Post Traumatic Stress Disorder (PTSD)
Neuropeptide Y - Posttraumatic Stress Disorder
Phase 1CompletedJames Murrough262012-12-012016-04-14
Continuation Ketamine in Major Depression
Lithium, Ketamine - Major Depressive Disorder
Phase 1CompletedJames Murrough362007-10-012014-05-23

Conditions studied

Depressive Disorder, Major (1)  ·  Diabetes Mellitus (1)  ·  Stress Disorders, Post-Traumatic (1)  ·  Wounds and Injuries (1)

Interventions

Ketamine (1)  ·  Lithium (1)  ·  Lithium Carbonate (1)  ·  Neuropeptide Y (1)

Countries

United States (3)

Top investigators

James W Murrough, MD (1)

Results publications

PMID 19545857, PMID 19897179, PMID 21450159, PMID 25271445, PMID 29186416, PMID 39301926

NIH funding

R01DK128242 (1)